Legal & General Group PLC Harpoon Therapeutics, Inc. Transaction History

Legal & General Group PLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 22, 2022	SELL	$1.78 - $5.02 $3,519 - $9,924	-1,977 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$13.81 - $23.25 $6,974 - $11,741	505 Added 34.31%	1,977 $27,000
Q1 2021 May 17, 2021	BUY	$17.65 - $24.16 $2,523 - $3,454	143 Added 10.76%	1,472 $31,000
Q3 2020 Nov 13, 2020	SELL	$11.01 - $18.52 $4,536 - $7,630	-412 Reduced 23.66%	1,329 $23,000
Q2 2020 Aug 14, 2020	BUY	$11.11 - $24.72 $7,021 - $15,623	632 Added 56.99%	1,741 $29,000
Q1 2020 May 14, 2020	SELL	$10.74 - $16.32 $2,223 - $3,378	-207 Reduced 15.73%	1,109 $13,000
Q4 2019 Feb 13, 2020	BUY	$12.94 - $20.58 $1,501 - $2,387	116 Added 9.67%	1,316 $21,000
Q3 2019 Nov 13, 2019	BUY	$10.93 - $17.47 $5,683 - $9,084	520 Added 76.47%	1,200 $16,000
Q1 2019 May 15, 2019	BUY	$9.47 - $17.01 $6,439 - $11,566	680 New	680 $6,000

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.